Effects on axonal conduction of anti-ganglioside sera and sera from patients with Guillain-Barré syndrome (Q73508025)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12799030%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

title

Effects on axonal conduction of anti-ganglioside sera and sera from patients with Guillain-Barré syndrome (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12799030%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

main subject

Guillain–Barré syndrome

1 reference

A Dilley

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12799030%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

N A Gregson

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12799030%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

R D M Hadden

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12799030%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

K J Smith

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12799030%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

publication date

1 June 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12799030%20AND%20SRC:MED&resulttype=core&format=json

Journal of Neuroimmunology

4 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12799030%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

volume

139

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12799030%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

issue

1-2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12799030%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

page(s)

133-140

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12799030%20AND%20SRC:MED&resulttype=core&format=json

Association between Campylobacter infection and Guillain-Barré syndrome

4 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900156-5

7 January 2021

Acute conduction block in vitro following exposure to antiganglioside sera.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900156-5

7 January 2021

The pattern of antiganglioside antibody reactivities producing myelinated nerve conduction block in vitro.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900156-5

7 January 2021

Immune-mediated peripheral neuropathies and voltage-gated sodiums channels

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900156-5

7 January 2021

Reversible proximal conduction block underlies rapid recovery in Guillain-Barré syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900156-5

7 January 2021

The acute paralysis in Guillain-Barré syndrome is related to a Na+ channel blocking factor in the cerebrospinal fluid

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900156-5

7 January 2021

Factors in the cerebrospinal fluid of multiple sclerosis patients interfering with voltage-dependent sodium channels

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900156-5

7 January 2021

An endogenous pentapeptide acting as a sodium channel blocker in inflammatory autoimmune disorders of the central nervous system.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900156-5

7 January 2021

Immunoglobulin G from a patient with Miller-Fisher syndrome rapidly and reversibly depresses evoked quantal release at the neuromuscular junction of mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900156-5

7 January 2021

Neuromuscular blockade by immunoglobulin G from patients with Miller Fisher syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900156-5

7 January 2021

Neuromuscular blockade by IgG antibodies from patients with Guillain-Barré syndrome: a macro-patch-clamp study

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900156-5

7 January 2021

Combined pre- and postsynaptic action of IgG antibodies in Miller Fisher syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900156-5

7 January 2021

Localization of GM1 and Gal(beta 1-3)GalNAc antigenic determinants in peripheral nerve

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900156-5

7 January 2021

Drain the roots: a new treatment for Guillain-Barré syndrome?

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900156-5

7 January 2021

An Unusual Variant of Acute Idiopathic Polyneuritis (Syndrome of Ophthalmoplegia, Ataxia and Areflexia)

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900156-5

7 January 2021

Efficiency of plasma exchange in Guillain-Barré syndrome: role of replacement fluids. French Cooperative Group on Plasma Exchange in Guillain-Barré syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900156-5

7 January 2021

Monoclonal antibodies raised against Guillain-Barré syndrome-associated Campylobacter jejuni lipopolysaccharides react with neuronal gangliosides and paralyze muscle-nerve preparations.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900156-5

7 January 2021

Electrophysiological classification of Guillain-Barré syndrome: clinical associations and outcome. Plasma Exchange/Sandoglobulin Guillain-Barré Syndrome Trial Group

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900156-5

7 January 2021

Preceding infections, immune factors, and outcome in Guillain-Barré syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900156-5

7 January 2021

Demyelination induced by serum from patients with Guillain-Barré syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900156-5

7 January 2021

Failure of anti-GM1 IgG or IgM to induce conduction block following intraneural transfer

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900156-5

7 January 2021

The physiological effect of anti-GM1 antibodies on saltatory conduction and transmembrane currents in single motor axons

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900156-5

7 January 2021

Patterns of recovery in the Guillain-Barre syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900156-5

7 January 2021

Pathogenesis of Guillain-Barré syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900156-5

7 January 2021

The spectrum of antecedent infections in Guillain-Barre syndrome: A case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900156-5

7 January 2021

Detection and prevalence of alpha-latrotoxin-like effects of serum from patients with Guillain-Barré syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900156-5

7 January 2021

Cerebrospinal fluid from multiple sclerosis patients inactivates neuronal Na+ current.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900156-5

7 January 2021

IgG anti-GM1 antibody is associated with reversible conduction failure and axonal degeneration in Guillain-Barré syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900156-5

7 January 2021

Two patterns of clinical recovery in Guillain-Barré syndrome with IgG anti-GM1 antibody

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900156-5

7 January 2021

Axonal involvement at the common entrapment sites in Guillain-Barré syndrome with IgG anti-GM1 antibody

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900156-5

7 January 2021

Endoneurial effects of sera from patients with acute inflammatory polyradiculoneuropathy: electrophysiologic studies on normal and demyelinated rat nerves

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900156-5

7 January 2021

Anti‐GM1 IgG antibodies and campylobacter bacteria in Guillain‐Barré syndrome: Evidence of molecular mimicry

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900156-5

7 January 2021

Anti-ganglioside antibodies can bind peripheral nerve nodes of Ranvier and activate the complement cascade without inducing acute conduction block in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900156-5

7 January 2021

Miller Fisher anti-GQ1b antibodies: alpha-latrotoxin-like effects on motor end plates

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900156-5

7 January 2021

Nitric oxide donors reversibly block axonal conduction: demyelinated axons are especially susceptible

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900156-5

7 January 2021

Campylobacter jejuni infection and Guillain-Barré syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900156-5

7 January 2021

Anti-ganglioside GM1 antibodies in Guillain-Barré syndrome and their relationship to Campylobacter jejuni infection

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900156-5

7 January 2021

Serum factor in Miller-Fisher variant of Guillain-Barré syndrome and neurotransmitter release

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900156-5

7 January 2021

Experimental conduction block induced by serum from a patient with anti-GM1 antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900156-5

7 January 2021

Rapid resolution of nerve conduction blocks after plasmapheresis in Guillain-Barré syndrome associated with anti-GM1b IgG antibody

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900156-5

7 January 2021

Antibodies against GM1 ganglioside affect K+ and Na+ currents in isolated rat myelinated nerve fibers

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900156-5

7 January 2021

The sera from GM1 ganglioside antibody positive patients with Guillain-Barré syndrome or chronic inflammatory demyelinating polyneuropathy blocks Na+ currents in rat single myelinated nerve fibers

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900156-5

7 January 2021

Experimental autoimmune neuropathy with anti-GM1 antibodies and immunoglobulin deposits at the nodes of Ranvier

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900156-5

7 January 2021

Conduction abnormalities induced by sera of patients with multifocal motor neuropathy and anti-GM1 antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900156-5

7 January 2021

Anti-GM1 antibodies can block neuronal voltage-gated sodium channels

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900156-5

7 January 2021

The endogenous pentapeptide QYNAD induces acute conduction block in the isolated rat sciatic nerve.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900156-5

7 January 2021

Cerebrospinal fluid and serum from patients with inflammatory polyradiculoneuropathy have opposite effects on sodium channels

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900156-5

7 January 2021

Molecular mimicry between gangliosides and lipopolysaccharides of Campylobacter jejuni isolated from patients with Guillain-Barré syndrome and Miller Fisher syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900156-5

7 January 2021

10.1016/S0165-5728(03)00156-5

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12799030%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

1 reference